Introduction
The central importance of electrical isolation of the pulmonary veins (PVs) towards eliminating atrial fibrillation (AF) is well-established 1, 2 , but achieving this end-point using catheter ablation involves three principal challenges: (1) There is no universally applicable and validated means to directly visualise ablation lesion creation, either in terms of the transmural (TM) extent or radius; (2) The left atrial (LA) wall thickness is variable 3 , yet unknown to the operator, and while partial wall-thickness lesions result in electrical conduction gaps and recurrent AF 2, 4 , excessive energy delivery risks life-threatening extracardiac thermal trauma 5 , and; (3) Cardiac and respiratory cycle-induced motion creates a moving target for radiofrequency (RF)-based catheter ablation technologies.
Theoretically, idealised pulmonary vein isolation (PVI) protocols are likely to involve variable energy dosing according to the LA wall thickness, with real-time incorporation of suitable measures of the tissue effects of energy delivery -i.e. lesion transmurality and radius -into a 3D "model" using objective and validated methods. When supported by suitable methodology for defining a stable point of catheter-tissue interaction during RF application, such "modelling" should facilitate the knowing completion of permanent PVI, without extracardiac thermal trauma, in all but exceptional cases and for all suitably skilled operators.
Important progress towards this goal has been reported in studies utilising the objective RF annotation module VISITAG™ (Biosense Webster Inc., Diamond Bar, CA), with a coordinated series of methodological steps towards tailored contact force (CF)-guided PVI lesion sets, including targeting minimum permissible inter-lesion distance (ILD) and sitespecific RF energy delivery (i.e. anterior versus posterior wall) according to a weighted formula incorporating measures of RF power, duration and CF. 6, 7 However, although very high clinical success has been achieved in selected operators' practice, these protocols fail to 6 represent perfect descriptors of reproducible and suitably tailored PVI protocols in four important respects:
(1) Studies of RF delivery during PVI in humans have provided evidence of greater effect at left-sided LA posterior wall (LAPW) sites 8, 9 , therefore any protocol without suitable energy dosing adjustment is likely to incur increased risk of extra-cardiac thermal trauma;
(2) There was no incorporation of measures of the TM tissue response to RF delivery, yet in vivo animal studies have demonstrated that a change in the unipolar electrogram (UE) morphology from RS to "pure R" may be indicative of histologically-confirmed TM lesions. 10, 11 Furthermore, a study conducted in humans has confirmed the utility of RF titration according to real-time assessments of pure R UE morphology change towards a highly effective CF-guided PVI protocol 12 ; (3) The chosen VISITAG™ Module CF filter settings (force-over-time 30%, minimum 5g 13 and 30% minimum 4g 7 ) permit variable out-of-phase catheter-tissue interaction due to intermittent catheter-tissue contact (i.e. 0g CF), though with RF annotation on-going and displayed / modelled as a single point; Therefore, the purpose of this present report was to retrospectively investigate the effects of ACCURESP™ respiratory adjustment setting on RF lesion modelling using the VISITAG™ Module, thereby determining the most appropriate ACCURESP™ setting for RF lesion annotation during CF and VISITAG™ Module-guided PVI. training re-checked. The tidal volume was never deliberately increased, so ACCURESP™ respiratory motion detection was negative in some cases. Importantly, even in cases where the ACCURESP™ respiratory adjustment threshold was triggered, the ACCURESP™ setting "on" was never prospectively applied to the VISITAG™ Module filter preferences during ablation.
Temperature-controlled RF at 30W (17ml/min irrigation) was delivered via a ThermoCool® SmartTouch® catheter using Agilis™ NxT sheath (Abbott, St Paul, MN) support during proximal pole CS pacing at 600ms. VISITAG™ Module filter preferences for automated RF annotation were: Positional stability range 2mm, tag display duration 3s; force-over-time 100% minimum 1g (the latter derived from a previous study 15 
Analysis
The question was whether ACCURESP™ "on" versus "off" settings resulted in significant differences in the number of annotated LAPW sites, annotated RF duration, ILD, total impedance drop, mean CF and FTI. ACCURESP™ "on" versus "off" annotation timing accuracy was assessed at all site 1-to-2 ablation catheter transitions (i.e. site 1-to-2 transitions at the commencement of each of the left and right PVI encirclement) by visual inspection of reconstituted catheter position, CF and impedance curves. These were considered important since the accuracy of ablation catheter motion detection away from any annotated site of RF delivery is equally important for both point-by-point and continuous RF ablation protocols.
Ablation catheter motion associated with transition between annotated sites 1-to-2 was identified according to either of the following criteria:
(1) Site 1 annotation "end" due to a 0g CF event (i.e. CF breaching the VISITAG™ Module force-over-time filter of 100% minimum 1g);
(2) Inter-ablation site transition during constant catheter-tissue contact, but accompanied by UE morphology change from pure R at site 1 completion, to RS at site 2 onset (i.e. indicating movement from a site of TM ablation effect to an adjacent ablation naive site).
By definition, all remaining site 1-to-2 transitions occurred during constant catheter-tissue contact and were effected with pure R UE morphology at both site 1 completion and site 2 onset; subsequent LAPW annotated transitions (sites 2-to-3, 3-to-4 and 4-to-5) were similarly identified and described.
VISITAG™ Module data comprising the x,y,z coordinates of the catheter tip position unadjusted for respiratory motion (i.e. using the "RawPositions" data file) and measured at 60 positions per second were exported to R 16 for analysis. The standard deviation (SD) over a rolling one second period -as utilised by the CARTO ® 3 system for position stability 10 annotation -was calculated in R from the Euclidean distances shifted between each position.
These "position stability" data were plotted according to the patient interface unit (PIU)
"system" time and supplemented with the absolute CF (at 20Hz) and impedance (at 10Hz) data derived from the exported "ContactForceData" "AblationData" files respectively, and end-expiration timing data from the "EndExperium" file. Finally, PIU start and stop times for all annotated sites according to each ACCURESP™ setting were obtained from the respective "AblationSites" files.
Statistics
Exported text files were converted to Excel data and imported to GraphPad Prism version 4.03 (GraphPad Software, San Diego, CA) for analysis. Comparisons were made between the ACCURESP™ "on" and "off" settings based on the means and standard deviations of biophysical data (i.e. ILD, RF duration, CF, impedance drop and FTI), or medians along with the 1 st and 3 rd quartile (IQR), where these were determined to be skewed. Differences in the biophysical data between the ACCURESP™ "on" versus "off" settings were tested using the unpaired t-test, or the Mann-Whitney test where data could not be assumed to be normally distributed. The Pearson correlation coefficient was calculated to determine the strength of association between ACCURESP™ set "off" ILD and the difference (ACCURESP™ "on" minus "off") in RF duration, FTI and ILD. In this exploratory analysis, significance was set at the 5% level.
Results
Twenty-five patients underwent first-time PVI as described, between November 2016 and were no significant differences between the cohorts with and without ACCURESP™ threshold triggering.
Comparing ACCURESP™ "on" versus "off", the number of annotated LAPW sites and total LAPW RF duration were 82 and 98, and 1091s and 1006s, respectively (annotated biophysical RF data according to ACCURESP™ setting are shown in Comparing the annotated biophysical data (ACCURESP™ "on" minus "off") at three site 1-to-2 annotated transitions concurrent with 0g CF, the maximum difference in annotated RF duration, FTI and ILD was -0.6s, -17g.s and 2.2mm respectively, with no difference in annotated impedance drop (table 3 and figures 1-3).
Four site 1-to-2 annotated transitions were effected with constant catheter-tissue contact and associated with UE morphology change from pure R (site 1 completion) to RS (site 2 onset).
In this group, the maximum difference (ACCURESP™ "on" minus "off") in RF duration, FTI, ILD and impedance drop was 11.3s, 139g.s, 2.6mm and 3.3Ω respectively (table 3) , with the first indication of catheter movement represented by ACCURESP™ "off" annotation in all cases (figures 4-7). The greatest difference was seen in a case where site 1-to-2 ILD with ACCURESP™ "off" was 4.1mm (reconstituted data curves, figure 4) ; at 15.2s following RF onset there was an abrupt increase in catheter position shift and SD, with a corresponding change in CF waveform, yet while the blue vertical line indicating annotation site 1-to-2 transition according to ACCURESP™ "off" coincided with these changes and the "per protocol" ~15s RF at site 1, the red vertical line indicating annotated site 1-to-2 transition using ACCURESP™ "on" is shown occurring 11.3s later. However, considering multiple measures of catheter position stability, the first indication of catheter motion was appropriately identified with ACCURESP™ "off" in eight transitions;
only one demonstrated a difference in annotation timing without clinical importance (i.e.
0.1s, supplementary figure 8).
For all thirteen site 1-to-2 transitions achieved with constant catheter-tissue contact, the relationship between differences in annotated RF data (ACCURESP™ "on" minus "off") and 
Discussion
The main findings of this present study are as follows: (1 ACCURESP™ setting was only without significant effect on RF annotation timing when sites of deliberate catheter motion were accompanied by loss of catheter-tissue contact (i.e.
0g CF) and while using a force-over-time filter of 100% minimum 1g; (4) There was a significant inverse relationship between the difference in first-annotated site RF duration (ACCURESP™ "on" minus "off"), and the ACCURESP™ "off" site 1-to-2 ILD.
Consequently, with ACCURESP™ "on", catheter tip motion of up to 7mm was not immediately identified, resulting in delayed annotation of site 1-to-2 transition and important error in per-site RF parameters. More simply, ACCURESP "on" may effectively render an 15 operator "blind" to the immediate occurrence of small but clinically important catheter displacement events.
These results may be better understood when considering the VISITAG™ Module annotation "system logic" and how this is modified by ACCURESP™ use. Briefly, the ablation catheter tip position is measured in a "rolling window" of 60 sites per second (i.e. intervals of 16/17ms), from which is calculated the standard deviation (SD). With ACCURESP™ "off", RF annotation occurs when both every second of position data is within twice (2x) the userdefined position SD, and a total consecutive minimum of 3s is within (1x) the SD. However, with ACCURESP™ "on", the position stability filter operates over a minimum of two respiratory cycles, using position data "adjusted" to end-expiration; here, automated ablation site annotation occurs when these position stability targets are met following data adjustment.
Importantly, annotation only occurs when CF filter preferences are also satisfied. However, in contrast to position stability filtering, the CF filter is applied continuously regardless of ACCURESP™ setting (i.e. independent of the respiratory cycle). Therefore, with the forceover-time 100% minimum 1g CF filter used during this present report, RF annotation "end" logic is fulfilled by any 0g CF event at any stage in the respiratory cycle, with ACCURESP™ both "on" and "off". procedures performed under GA and with IPPV failing to trigger ACCURESP™ had the tidal volume increased to ensure ACCURESP™ triggering and "on" setting use (Molloy Das, personal communication). 13 As this present report has demonstrated that catheter tip movements of up to 7mm are not immediately identified with ACCURESP™ "on", these previously identified ablation targets are likely to be importantly flawed.
Importance of these findings: Historical perspective

Clinical importance in light of novel high power, short per-site RF duration protocols
RF lesion formation occurs more rapidly at higher power. 17 Recently reported high power short duration (HPSD) protocols (50W, typically ~5s per site) 18, 19 are particularly attractive for operators wishing to move away from the requirement to maintain a stable catheter position for the ~20-40s previously considered necessary to achieve TM RF effect during PVI. 1, 20 A greater rate of lesion formation means HPSD protocols are particularly dependent upon suitable methodology towards the immediate and accurate determination of clinically relevant catheter position instability. However, to our knowledge no HPSD manuscript includes details of whether respiratory adjustment was applied to RF annotation logic.
Alongside the recommendation (from Biosense Webster) for routine VISITAG™ Module use with ACCURESP™ "on", this calls into question the validity of such HPSD "per-site" ablation targets (since they were likely to have been performed using RF annotation with respiratory adjustment) and whether present HPSD protocols may be considered Also, a complete description of the effects of changing the position stability filter setting is beyond the scope of this present report; this will be the subject of a future manuscript.
Catheter tip motion characteristics following deliberate movement may importantly differ from unintentional events; due to the very high attainment of target per-site RF delivery in this present report, a description of position stability, CF and impedance profiles at sites of accidental catheter motion is beyond the scope of this present report. However, when deliberate catheter displacement events of up to ~5-7mm were not immediately identified 19 when using annotation with ACCURESP™ "on", similar degrees of movement during unintentional catheter displacement events are likely to be missed.
The findings of this present report can only be directly applied to VISITAG™ Moduleguided PVI. However, EnSite Precision™ (Abbott) -the only other system with an automated RF annotation module, AutoMark™ -also utilises respiratory motion compensation logic. Importantly, EnSite Precision™ employs permanent RF data and electrogram storage; accordingly, the findings of this present report may help stimulate retrospective investigations into the methodological rigour of different AutoMark™ annotation settings during AF ablation.
It remains impossible to determine the site-specific magnitude of any out-of-phase catheter tissue interaction occurring during constant contact using the methodology described in this present report; intra-cardiac echo was never used. Therefore, even with ACCURESP™ "off", respiratory motion may represent an important determinant of the recently identified heterogeneity in RF effect during PVI. 9, 22, 23 Furthermore, cardiac cycle-induced motion may represent another important determinant of catheter instability, although atrial overdrive pacing during RF delivery has been demonstrated to improve catheter stability and impedance reduction; 24 this technique was also used in this present report.
Finally, this report is based on analyses of 8 PVI procedures from a total cohort of 25 patients -i.e. a small sample size from which to conventionally derive meaningful data. However, RF annotation-guided ablation represents a very "data-rich" operative environment and analyses for each ~15s first-site RF application alone utilise 3090 exported data points (i.e. CF at 20Hz, impedance at 10Hz, and both position SD and position shift at 60Hz). Therefore, although drawn from an eight-patient cohort, the findings of this present report represent a total analysis of ~165,000 data points.
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Conclusions
During CF and VISITAG™ Module annotation-guided PVI, ACCURESP™ respiratory adjustment results in important delays to the identification and annotation of sites of deliberate catheter motion of up to 5-7mm at the LAPW. Therefore, previously derived ablation targets using ACCURESP™ set "on" may be importantly flawed, and on-going respiratory adjustment use is likely to represent an important impediment towards greater PVI procedural reproducibility, efficacy and safety. In contrast, RF annotation with ACCURESP™ set "off" demonstrated suitable catheter motion detection capabilities. Based on these findings, we recommend setting ACCURESP™ "off" during VISITAG™ Module and CF-guided PVI. indicates the number of LAPW annotated sites identified and used for analyses of the remaining variables. Table 2 : Annotated biophysical data at first-annotated LAPW sites according to ACCURESP™ setting (i.e. "on" versus "off") and site; data shown are median (1 st -3 rd quartile). Table 3 : Annotated biophysical data at site 1-to-2 transition, with deliberate catheter movement identified according to criteria of a 0g CF event, or change in the UE morphology from pure R (site 1 completion) to RS (site 2 onset). Annotated site 1 RF duration, site 1-to-2 ILD, impedance drop and FTI data are displayed according to ACCURESP™ setting, with the difference ("Diff" -i.e. ACCURESP™ "on" minus "off") also shown; PV, pulmonary vein. Table 4 31 Inter-site distance (mm) δ Annotated FTI (g.s)
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